Differential diagnosis in a primary care population with presumed airway obstruction: A real-life study

Respiration

Volumn 84, Issue 1, 2012, Pages 44-54

  Buffels, Johan ^a   Degryse, Jan ^a,c,e   Liistro, Giuseppe ^d   Decramer, Marc ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e NONE   (Belgium)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Diagnostic accuracy; Differential diagnosis; Family practice; Spirometry

Indexed keywords

BUDESONIDE; FLUTICASONE; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; GOLD STANDARD; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OXYGEN SATURATION; POPULATION RESEARCH; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; QUESTIONNAIRE; RESPIROMETRY; THORAX RADIOGRAPHY;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL COMPETENCE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; GENERAL PRACTICE; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84863512579     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000332836     Document Type: Article

References (42)

1. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176: 532-555.
2. Global Initiative for Asthma: Global strategy for asthma management and prevention. www.ginasthma.com. Last updated December, 2010.
3. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ: Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 2000; 161: 1720-1745.
4. Robinson DS, Hamid Q, Ying S, et al: Predominant TH2-like broncho-alveolar Tlymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
5. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK: Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV 1. Am J Respir Crit Care Med 1997; 155: 1277-1285.
6. Lacoste JY, Bousquet J, Chanez P, et al: Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis and chronic obstructive pulmonary disease. Eur Respir J 1998; 12: 380-386.
7. Celli BR: The importance of spirometry in COPD and asthma. Effect on approach to management. Chest 2000; 117: 15s-19s. (Pubitemid 30111558)
8. Martinez FJ: Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema and chronic bronchitis. Postgrad Med 1998; 103: 112-125. (Pubitemid 28227428)
9. Thomson NC, Chaudhuri R, Livingston E: Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-833. (Pubitemid 39504438)
10. Ulrik CS, Backer V: Nonreversible airflow obstruction in life-long non-smokers with moderate to severe asthma. Eur Respir J 1999; 14: 892-896. (Pubitemid 29519354)
11. Bumbacea D, Campbell D, Nguyen L, et al: Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004; 24: 122-128. (Pubitemid 39029077)
12. Calverley PMA, Burge PS, Spencer S, et al: Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664. (Pubitemid 36976273)
13. van Schayck CP: Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. Br J Gen Pract 1996; 46: 193-197. (Pubitemid 26092861)
14. Griffiths C, Feder G, Wedzicha J, et al: Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. Respir Med 1999; 93: 903-908. (Pubitemid 30042642)
15. Bellia V, Battaglia S, Catalano F, et al: Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003; 123: 1066-1072. (Pubitemid 36444362)
16. Bourdin A, Serre I, Flamme H, et al: Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? Thorax 2004; 59: 488-493. (Pubitemid 38797521)
17. Yawn BP, Enright PL, Lemanske EI, et al: Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007; 132: 1162-1168. (Pubitemid 47620988)
18. Tinkelman DG, Price DB, Nordyke RJ, et al: Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43: 75-80.
19. Sichletidis L, Chloros D, Spyratos D, et al: The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J 2007; 16: 82-88. (Pubitemid 46698771)
20. Lindberg A, Jonsson A, Rönmark E, Lundgren R, Larsson L, Lundbäck B: Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender and smoking habits. Respiration 2005; 72: 471-479. (Pubitemid 41433561)
21. Buffels J, Degryse J, Liistro G: Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction. The DIDASCO2 study. Prim Care Respir J 2009; 1:34-40.
22. Chavannes N, Schermer T, Akkermans R, et al: Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med 2004; 98: 1124-1130. (Pubitemid 39317943)
23. Dales RE, Vandemheen KL, Clinch J, et al: Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest 2005; 128: 1443-1447.
24. Tinkelman DG, Price DB, Nordyke RJ, et al: Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006; 73: 296-305. (Pubitemid 43725786)
25. Miravitlles M, Fernandez I, Guerrero T, et al: Development and results of a screening program for COPD in primary care. The PADOC Project (Program for the Increase in the Diagnosis of COPD in Primary Care) (in Spanish). Arch Bronconeumol 2000; 36: 500-505. (Pubitemid 33676211)
26. van der Valk P, Monninkhof E, van der Palen J, et al: Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 2002; 166: 1358-1363. (Pubitemid 35292702)
27. Wouters EF, Postma DS, Fokkens B, et al: Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 2005; 61: 29-33.
28. van der Palen J, Monninkhof E, van der Valk P, et al: Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease. Thorax 2006; 60: 480-487.
29. Brand PL, Quanjer PH, Postma DS, et al: Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47: 429-436.
30. Dompeling E, van Schayck CP, Molema J, et al: A comparison of six different ways of expressing the bronchodilator response in asthma and COPD: reproducibility and dependence of prebronchodilator FEV 1. Eur Respir J 1992; 5: 975-981.
31. Walker PP, Mitchell P, Diamantea F, et al: Effect of primary care spirometry on the diagnosis and management of COPD. Eur Respir J 2006; 28: 945-952. (Pubitemid 46331963)
32. Rutjes A, Reitsma J, Coomarasamy A, et al: Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess 2007; 11: 1-72.
33. Raghunath AS, Innes A, Norfolk L, et al: Difficulties in the interpretation of lung function tests in the diagnosis of asthma and chronic obstructive pulmonary disease. J Asthma 2006; 43: 657-660. (Pubitemid 44724879)
34. Marklund B, Tunsater A, Bengtsson C: How often is the diagnosis bronchial asthma correct? Fam Pract 1999; 16: 112-116. (Pubitemid 29255552)
35. Lusuardi M, De Benedetto F, Paggiaro P, et al: A randomised controlled trial on office spirometry in asthma and COPD in standard general practice. Chest 2006; 129: 844-852.
36. Tashkin D, Celli B, Kesten S, Lystig T, Decramer M: Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Respir Med 2010; 104: 1495-1504.
37. Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, et al: Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J 2010; 36: 65-73.
38. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620. (Pubitemid 39094180)
39. Barnes PJ, Kleinert S: COPD-a neglected disease. Lancet 2004; 364: 563-564.
40. Rennard S: Treatment of stable chronic obstructive pulmonary disease. Lancet 2004; 364: 791-802. (Pubitemid 39165101)
41. Pearson M, Ayres J, Sarno M, et al: Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997-2001. Int J Chron Obstruct Pulmon Dis 2006; 1: 435-443.
42. Visser FJ, van der Vegt MJ, van der Wilt GJ, Janssen JP: The optimization of the diagnostic work-up in patients with suspected obstructive lung disease. BMC Pulm Med 2010; 10: 60.